Live Chemotherapy updates

Live Chemotherapy news coverage of developments with the latest updates. Stay on top of latest Chemotherapy news stories and find out what just happened, what is going on with Chemotherapy. The latest real-time news updates and headlines on Chemotherapy
Immune System's Drug Attack May Boost Cancer Therapy
Fat But Fit Study: New Findings Unveiled
Rare Uterine Tumors With Pregnancy Traits Linked to Poor Survival
Cancer Societies Revise Post-Mastectomy Radiation Guide
Lymph Node Corruption Prevention
Nuclear Receptors Targeted in Brain Cancer Therapy
Biotech Vector Boosts Cancer Therapy Via RNA Delivery
Liver Cancer Surge Meets Hopeful Treatment Breakthroughs
Vorasidenib OK'd for Grade 2 Brain Tumors in Adolescents
Getting Right Breast Cancer Therapy To Right Patient
Nuclear Medicine Journal Preview: Sept 12, 2025
From Crash In Ditch To Forefront Of Research
Tindal Launches Charity Campaign
Research Reveals Financial Strain's Impact on Cancer Patients
Telomere Health Crucial for Cancer-Fighting T Cells
Mouse Study Uncovers Brain's Consumption Switch
Misconceptions Hinder Hormone Therapy for Some Cancer Patients
ECU Study: Early Cancer Treatment Weakens Kids' Muscles
Can Nanobots Play Follow Leader?
Secretary of State Addresses King's Fund
Early Diagnosis, Targeted Therapy Key in Fibrosarcoma
AI Tool Predicts Infection Risks in Stem Cell Patients
Blood on Demand Tech Set to Transform Transfusions
Organ Chip That Predicts Response To Chemotherapy
New Model Could Optimize Drug Discovery
Bottlebrush Particles Target Cancer with Chemo Payloads
AI Tool Identifies Genes, Drug Combos for Cell Health
Research: Tumor DNA May Guide Immunotherapy in SCLC
Genetic Light Switches Revolutionize Disease Control
Chemotherapy's Impact on Circadian Rhythms Uncovered
Tarlatamab Combo Shows Safety, Extends Survival in ES-SCLC
Hollings Trial Explores Dual Treatment for Cancer, Heart Disease
BMS-986504 Shows Lasting Response in NSCLC Trials
Hypofractionated Radiotherapy Matches Conventional in LS-SCLC
EA5181 Phase 3: No OS Gain With Concurrent Durvalumab
NADIM ADJUVANT Trial: Chemo-Immunotherapy Boosts NSCLC Outcomes
Surgery Patients Face Persistent Opioid Use Risk
Kids, Bugs & Drugs: Human-Microbe Family Dynamics
Ifinatamab Deruxtecan Shows Promise in Lung Cancer Trial
Crizotinib Ineffective for Early-Stage ALK+ NSCLC
Ivonescimab Boosts Survival in EGFR+ NSCLC Patients
FLAURA2: Osimertinib, Chemo Boost Survival in EGFR NSCLC
Osimertinib Plus Chemo Boosts Survival in EGFR NSCLC
CheckMate 77T: Nivolumab Boosts Quality, Eases NSCLC Symptoms
MD Anderson Unveils Key Research Highlights, Sept. 2025
Markey Networks Deliver Latest Trials to Patients
Advancing Safer, Effective Childhood Cancer Therapies
USC Scientists Unlock Lab-Grown Kidney Cell Blueprint